Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34358 | 73 | 36.5 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TNFAIP8 | Author keyword | 21 | 90% | 12% | 9 |
2 | TIPE2 | Author keyword | 9 | 83% | 7% | 5 |
3 | TNFAIP8L2 TIPE2 | Author keyword | 8 | 100% | 7% | 5 |
4 | SCC S2 | Author keyword | 6 | 100% | 5% | 4 |
5 | TUMOUR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8 LIKE 2 | Author keyword | 3 | 100% | 4% | 3 |
6 | MYXOMA RESISTANCE PROTEIN 1 | Author keyword | 1 | 100% | 3% | 2 |
7 | TNFAIP8L2 | Author keyword | 1 | 100% | 3% | 2 |
8 | TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8 | Author keyword | 1 | 100% | 3% | 2 |
9 | TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8 LIKE 2 | Author keyword | 1 | 50% | 3% | 2 |
10 | DUAL LUCIFERASE REPORTER | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SCC S2 | 48 | 91% | 27% | 20 |
2 | TNFAIP8 | 14 | 100% | 10% | 7 |
3 | TIPE2 | 13 | 80% | 11% | 8 |
4 | IMMUNE HOMEOSTASIS | 11 | 28% | 45% | 33 |
5 | DEATH EFFECTOR DOMAIN | 2 | 13% | 23% | 17 |
6 | TNFAIP8 FAMILY | 2 | 67% | 3% | 2 |
7 | INDUCED PROTEIN 8 | 1 | 100% | 3% | 2 |
8 | TNFAIP8 OVEREXPRESSION | 1 | 50% | 1% | 1 |
9 | HEMEOXYGENASE 1 | 0 | 11% | 1% | 1 |
10 | ATTENUATES EXPERIMENTAL COLITIS | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The TIPE (TNFAIP8) family in inflammation, immunity, and cancer | 2011 | 15 | 30 | 63% |
Update on the Immunological Pathway of Negative Regulation in Acute Insults and Sepsis | 2012 | 0 | 103 | 6% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | USU MED PROTE | 1 | 50% | 1.4% | 1 |
2 | CHILDRENS MED DIAG | 0 | 25% | 1.4% | 1 |
3 | STELLAR CHANCE S 713 | 0 | 25% | 1.4% | 1 |
4 | NANTONG RICH HOSP | 0 | 100% | 1.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000077936 | ACHYRANTHES ASPERA//ARGYREIA SPECIOSA//FICUS THONNINGII |
2 | 0.0000073431 | NECROPTOSIS//RIP3//NECROSTATIN 1 |
3 | 0.0000065310 | RLIP76//RALBP1//RAL |
4 | 0.0000065121 | NON HODGKIN//ENVIRONM EPIDEMIOL CANC GRP//EPIDEMIOL GENET UNIT |
5 | 0.0000064006 | LIPOSOMAL VALINOMYCIN//AGR LIFE SCI BACTERIOL//TETANUS TOXOID ANTIGEN |
6 | 0.0000060725 | PATHOGENESE VIRUS HEPATITE B//WOODCHUCK HEPATITIS VIRUS//WOODCHUCK |
7 | 0.0000057319 | A20//STRESS ASSOCIATED PROTEIN//ZINC FINGER PROTEIN A20 |
8 | 0.0000051533 | TEMPORAL METHOD//EFFECTIVE POPULATION SIZE//N E N RATIO |
9 | 0.0000049427 | SALIDROSIDE//RHODIOLA ROSEA//RHODIOLA ROSEA L |
10 | 0.0000048097 | TR4//GERM CELL NUCLEAR FACTOR//GCNF |